About Seegene Technologies
Seegene Technologies is a company based in Seoul (South Korea) founded in 2000 was acquired by Pfizer in March 2023.. The company has 862 employees as of December 31, 2024. Seegene Technologies has completed 1 acquisition, including BREX. Seegene Technologies operates in a competitive market with competitors including Avidity Biosciences, Prenetics, Univercells, Sutro Biopharma and OpGen, among others.
- Headquarter Seoul, South Korea
- Employees 862 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Seegene, Inc.
-
Annual Revenue
$280.86 M (USD)12.76as on Dec 31, 2024
-
Net Profit
$-13.79 M (USD)-3139.83as on Dec 31, 2024
-
EBITDA
$37.1 M (USD)53.45as on Dec 31, 2024
-
Latest Funding Round
$1.59 M (USD), Grant
Dec 01, 2019
-
Investors
Pfizer
& 1 more
-
Employee Count
862
as on Dec 31, 2024
- Investments & Acquisitions
-
Acquired by
Pfizer
(Mar 13, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Seegene Technologies
Seegene Technologies is a publicly listed company on the KRX with ticker symbol 096530 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Funding Insights of Seegene Technologies
- Total Funding Total Funding
- Total Rounds 1
- Last Round Grant — $1.6M
-
First Round
First Round
(01 Dec 2019)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2019 | Amount | Grant - Seegene Technologies | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Seegene Technologies
Seegene Technologies has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Pfizer and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Pharmaceutical products for treating multiple diseases are provided.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Seegene Technologies
Seegene Technologies has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include BREX. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
UI/UX consulting services are provided in Seoul, South Korea.
|
2019 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Seegene Technologies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Seegene Technologies Comparisons
Competitors of Seegene Technologies
Seegene Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Prenetics, Univercells, Sutro Biopharma and OpGen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Health risks are identified through online genetic and diagnostic testing.
|
|
| domain | founded_year | HQ Location |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Developer of diagnostics and bioinformatics platforms for providers
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Seegene Technologies
Frequently Asked Questions about Seegene Technologies
When was Seegene Technologies founded?
Seegene Technologies was founded in 2000 and raised its 1st funding round 19 years after it was founded.
Where is Seegene Technologies located?
Seegene Technologies is headquartered in Seoul, South Korea.
Who is the current CEO of Seegene Technologies?
Jong Yoon Chun is the current CEO of Seegene Technologies.
How many employees does Seegene Technologies have?
As of Dec 31, 2024, the latest employee count at Seegene Technologies is 862.
What is the annual revenue of Seegene Technologies?
Annual revenue of Seegene Technologies is $280.86M as on Dec 31, 2024.
What does Seegene Technologies do?
Seegene Technologies was founded in 2000 and is based in Seoul, South Korea. Operations focus on the molecular diagnostics sector, where in vitro diagnostic (IVD) tests are created to identify disease causes through nucleic acid analysis, including DNA and RNA. Reagents and kits are produced for conditions such as respiratory infections, gastrointestinal disorders, sexually transmitted diseases, human papillomavirus, tuberculosis, sepsis, and meningitis.
Who are the top competitors of Seegene Technologies?
Seegene Technologies's top competitors include Sutro Biopharma, Avidity Biosciences and Prenetics.
Is Seegene Technologies publicly traded?
Yes, Seegene Technologies is publicly traded on KRX under the ticker symbol 096530.
How many acquisitions has Seegene Technologies made?
Seegene Technologies has made 1 acquisition, including BREX.
Who are Seegene Technologies's investors?
What is Seegene Technologies's ticker symbol?
The ticker symbol of Seegene Technologies is 096530 on KRX.